“…The ABR test is noninvasive, safe, mobile, brief, objective, reliable, a sensitive and comprehensive index of neurological status, anatomically specific, highly independent of level of consciousness, highly resistant to the effects of drugs, cost-effective, and it has the potential to be automated. 4,5,[12][13][14]22,27 Limitations of the ABR as a Predictor of Outcome in Patients With Severe ACHI. Possibly the greatest limitation of the ABR as a predictor of outcome in patients with severe ACHI (at least numerically) is that 30 to 35% of these patients who present with normal ABR results on their initial assessment later die or remain in a persistent vegetative state.…”